文献速递小儿耳鼻咽喉咽喉与嗓音

儿童腺样体扁桃体切除术中单剂静脉对乙酰氨基酚的随机前瞻性评估

Randomized Prospective Evaluation of Intraoperative Intravenous Acetaminophen in Pediatric Adenotonsillectomy.
PubMed 文献 · Otolaryngol Head Neck Surg · 2017-09-05

本研究为单中心随机对照临床试验,纳入3至17岁接受扁桃体或腺样体扁桃体切除术的患儿260例,随机分为术中单剂静脉对乙酰氨基酚组与未使用者,比较术后24小时疼痛评分、镇痛药物使用及恢复时间。结果显示静脉对乙酰氨基酚组术后恶心呕吐发生率更高(1.53% vs 0.00%,P = .016),疼痛评分、补救镇痛需求、恢复室或出院时间及术后并发症均无显著差异。

要点

  • 术中单剂静脉对乙酰氨基酚未显著改善术后疼痛控制。
  • 静脉对乙酰氨基酚组术后恶心呕吐发生率高于未使用者。
  • 在标准化口服镇痛方案基础上加用该药未见额外获益。

核心结论

  • 在标准麻醉性及非麻醉性镇痛方案基础上加用术中单剂静脉对乙酰氨基酚,未在统计学上显著改善儿童腺样体扁桃体切除术后的疼痛控制。
  • 术中单剂静脉对乙酰氨基酚仅伴随极少的额外不良反应,但术后恶心呕吐发生率高于未使用者。

研究设计与样本

  • 随机对照前瞻性临床试验,单中心学术医疗中心开展。
  • 共纳入260例,其中131例(50.4%)接受术中单剂静脉对乙酰氨基酚。
  • 麻醉诱导与维持及手术技术均标准化,术后镇痛方案为交替口服对乙酰氨基酚与布洛芬。
  • 术后24小时内回顾护理疼痛评分、镇痛药物使用及恢复时间。

主要发现

  • 接受静脉对乙酰氨基酚者术后恶心呕吐发生率高于未接受者(1.53% vs 0.00%,P = .016)。
  • 术后疼痛评分、补救镇痛药物需求、恢复室或出院时间及术后并发症均无显著差异。

临床怎么用

  • 对于接受腺样体扁桃体切除术的儿童,在标准化口服镇痛方案基础上加用术中单剂静脉对乙酰氨基酚未见显著疼痛控制获益。
  • 选择术中静脉对乙酰氨基酚时需权衡其术后恶心呕吐风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To establish the safety and efficacy of single-dose intraoperative intravenous (IV) acetaminophen in postoperative pain management following adenotonsillectomy in addition to a standardized regimen of oral pain medication. Study Design Randomized, controlled prospective clinical trial. Setting Single academic medical center. Subjects and Methods Patients between the ages of 3 and 17 years scheduled for tonsillectomy or adenotonsillectomy by a single surgeon between December 2014 and November 2016 were recruited. Patients were randomly assigned to 1 of 2 groups; group 1 received a single intraoperative dose of IV acetaminophen, and group 2 did not. Induction and maintenance of anesthesia, as well as operative technique, were standardized. Nursing pain scores, pain medications administered, and recovery times were reviewed during the 24-hour postoperative period. Postoperative pain regimen included standing alternating oral acetaminophen and ibuprofen. Results In total, 260 patients were included in the study, and 131 (50.4%) received a single intraoperative dose of IV acetaminophen. Patients receiving IV acetaminophen were more likely to experience postoperative nausea and vomiting than patients who did not receive IV acetaminophen (1.53% vs 0.00%, P = .016). There were no significant differences noted for postoperative pain scores, requirements for breakthrough pain medications, time to discharge from the recovery room or hospital, or postoperative complications. Conclusion The use of a single intraoperative dose of IV acetaminophen was associated with minimal additional adverse effects. However, a single intraoperative IV dose of acetaminophen added to standard narcotic and nonnarcotic pain medication does not provide a statistically significant improvement in pain control.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Roberts CA, Shah-Becker S, O'Connell Ferster A, et al. Randomized Prospective Evaluation of Intraoperative Intravenous Acetaminophen in Pediatric Adenotonsillectomy. Otolaryngol Head Neck Surg. 2017. PMID: 28873028. doi:10.1177/0194599817728911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。